| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Can Fite Biofarma (AMEX:CANF) reported its Q4 earnings results on Thursday, March 28, 2024 at 07:00 AM.
Here's what investors need to know about the announcement.
Can Fite Biofarma beat estimated earnings by 96.0%, reporting an EPS of $-0.01 versus an estimate of $-0.26.
Revenue was down $42 thousand from the same period last year.
Last quarter the company beat on EPS by $0.01 which was followed by a 4.0% increase in the share price the next day.
To track all earnings releases for Can Fite Biofarma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: CANF
